Suppr超能文献

[丹毒预防的百年历程:动物实验的意义与减少]

[100 years of erysipelas prophylaxis: significance and reduction of animal experiments].

作者信息

Cussler K, Balks E

机构信息

Paul-Ehrlich-Institut, D-Langen.

出版信息

ALTEX. 2001;18(1):29-33.

Abstract

The history of erysipelas prophylaxis began in 1882 when Pasteur first discovered the attenuating effect of rabbit passages on the erysipelas bacterium. Ten years later, the German veterinarian Lorenz demonstrated the protecting effect of erysipelas antiserum. He developed a method of serovaccination which was successfully used in Germany for more than 50 years. Both scientists employed laboratory animals for the development of their live vaccines. Lorenz additionally recommended an animal model with grey mice to control the potency of erysipelas sera. In 1944, Fortner and Dinter published the results of their investigation on a skin scarification test in swine. This modus of infection was the basis of the first reliable model for efficacy testing of erysipelas vaccines in domestic animals. Shortly after World War II, the first inactivated erysipelas vaccines were being developed. At that time, also a strict quality control was introduced for this product group which required extensive animal experiments in laboratory mice and pigs for the determination of efficacy. WHO established International Standards for erysipelas vaccines and antisera concerning potency testing in mice. These animal models were finally incorporated in pharmacopoeia monographs. Animal experiments have played an important role in the development and quality control of erysipelas vaccines. And the success of this quality control based on animal experiments has had a significant impact on the quality control systems for veterinary vaccines in general. Today, we have a far more detailed knowledge about pathogenesis and immunology of swine erysipelas. This knowledge now allows the introduction of alternative methods according to the 3R concept. With these new methods, animal numbers can be decreased and suffering caused by challenge infection can be reduced. The ultimate goal, i.e. quality control of erysipelas vaccines carried out without routine performance of animal experiments, should be achieved in the near future.

摘要

丹毒预防的历史始于1882年,当时巴斯德首次发现兔传代对丹毒杆菌的减毒作用。十年后,德国兽医洛伦兹证明了丹毒抗血清的保护作用。他开发了一种血清接种方法,并在德国成功使用了50多年。两位科学家都使用实验动物来开发他们的活疫苗。洛伦兹还推荐使用灰鼠作为动物模型来控制丹毒血清的效力。1944年,福特纳和丁特发表了他们对猪皮肤划痕试验的研究结果。这种感染方式是家畜丹毒疫苗效力测试的第一个可靠模型的基础。第二次世界大战后不久,第一批灭活丹毒疫苗开始研发。当时,也对该产品组引入了严格的质量控制,这需要在实验室小鼠和猪身上进行广泛的动物实验来确定效力。世卫组织制定了关于小鼠效力测试的丹毒疫苗和抗血清国际标准。这些动物模型最终被纳入药典专论。动物实验在丹毒疫苗的研发和质量控制中发挥了重要作用。基于动物实验的这种质量控制的成功对一般兽医疫苗的质量控制系统产生了重大影响。如今,我们对猪丹毒的发病机制和免疫学有了更详细的了解。这些知识现在允许根据3R概念引入替代方法。通过这些新方法,可以减少动物数量,并减少由攻毒感染引起的痛苦。在不久的将来,应该能够实现不进行常规动物实验而对丹毒疫苗进行质量控制的最终目标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验